(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
Raouf S. Amin, MD Director, Division of Pulmonary Medicine 513-636-6771 firstname.lastname@example.org
Director, Division of Pulmonary Medicine
The Hubert and Dorothy Campbell Chair of Pediatric Pulmonology
Director, Rare Lung Diseases Program
Professor, UC Department of Pediatrics
Chronic respiratory failure; sleep disorders in children
Raouf S. Amin, MD, is the director of the Division of Pulmonary Medicine at Cincinnati Children's Hospital Medical Center and a professor for the UC Department of Pediatrics. He graduated from the University of Ain Shams in Cairo Egypt in 1977. Dr. Amin received clinical training in the United Kingdom and the United States. He completed a pulmonary fellowship at Cincinnati Children's Hospital Medical Center in 1993. His research focus is on cardiovascular morbidity of sleep disordered breathing in children. He has several funded protocols from the National Institute of Health.
MD: Aim Shams University, Cairo Egypt, 1978.
Residency: Pediatrics; Michigan State University, Flint, MI.
Certification: Pediatrics 1990; Pediatric Pulmonary Medicine 1994; Sleep Medicine, 1995.
Clancy JP, Rowe SM, Accurso FJ, Aitken ML, Amin RS, Ashlock MA, Ballmann M, Boyle MP, Bronsveld I, Campbell PW, Deboeck K, Donaldson SH, Dorkin HL, Dunitz JM, Durie PR, Jain M, Leonard A, McCoy KS, Moss RB, Pilewski JM, Rosenbluth DB, Rubenstein RC, Schechter MS, Botfield M, Ordoñez CL, Spencer-Green GT, Vernillet L, Wisseh S, Yen K, Konstan MW. Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax. 2012 Jan;67(1):12-8.
Sung V, Beebe DW, Vandyke R, Fenchel MC, Crimmins NA, Kirk S, Hiscock H, Amin R, Wake M. Does sleep duration predict metabolic risk in obese adolescents attending tertiary services? A cross-sectional study. Sleep. 2011 Jul 1;34(7):891-8.
Sawnani H, Murugappan S, Gutmark E, Donnelly LF, Amin R, Mylavarapu G, Mihaescu M, Khosla S, Kalra M. Influence of gender on pharyngeal airway length in obese adolescents. Ann Otol Rhinol Laryngol. 2010 Dec;119(12):842-7.
Beebe DW, Ris MD, Kramer ME, Long E, Amin R. The association between sleep disordered breathing, academic grades, and cognitive and behavioral functioning among overweight subjects during middle to late childhood. Sleep. 2010 Nov 1;33(11):1447-56.
Beebe DW, Rose D, Amin R. Attention, learning, and arousal of experimentally sleep-restricted adolescents in a simulated classroom. J Adolesc Health. 2010 Nov;47(5):523-5.
McPhail GL, Weiland J, Acton JD, Ednick M, Chima A, VanDyke R, Fenchel MC, Amin RS, Seid M. Improving evidence-based care in cystic fibrosis through quality improvement. Arch Pediatr Adolesc Med. 2010 Oct;164(10):957-60.
McPhail GL, Ednick MD, Fenchel MC, VanDyke R, Chima A, Amin RS, Seid M. Improving follow-up in hospitalised children. Qual Saf Health Care. 2010 Oct;19(5):e35.
Ednick M, Cohen AP, McPhail GL, Beebe D, Simakajornboon N, Amin RS. A review of the effects of sleep during the first year of life on cognitive, psychomotor, and temperament development. Sleep. 2009 Nov 1;32(11):1449-58.
Ednick M, Tinkle BT, Phromchairak J, Egelhoff J, Amin R, Simakajornboon N. Sleep-related respiratory abnormalities and arousal pattern in achondroplasia during early infancy. J Pediatr. 2009 Oct;155(4):510-5.
McConnell K, Somers VK, Kimball T, Daniels S, VanDyke R, Fenchel M, Cohen A, Willging P, Shamsuzzaman A, Amin R. Baroreflex gain in children with obstructive sleep apnea. Am J Respir Crit Care Med. 2009 Jul 1;180(1):42-8.
Ronald E. Bokulic, DO 513-636-6771
Associate Professor, UC Department of Pediatrics
Asthma; interstitial lung disease; exercise
DO: Philadelphia College of Osteopathic Medicine, 1983.
Residency: Pediatrics, Children's Medical Center, Dallas, TX.
Fellowship: Pediatric Pulmonary Medicine, Tulane University Medical School, New Orleans, LA.
Certification: Pediatrics, 1989; Pediatric Pulmonology, 1994.
Burrow TA, Cohen MB, Bokulic R, Deutsch G, Choudhary A, Falcone RA Jr, Grabowski GA. Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy. J Pediatr. 2007 Feb;150(2):202-6.
Amin RS, Carroll JL, Jeffries JL, Grone C, Bean JA, Chini B, Bokulic R, Daniels SR. Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing. Am J Respir Crit Care Med. 2004 Apr 15;169(8):950-6.
Evans DA, Bokulic RE. Radiological case of the month. Posttraumatic pseudocysts. Arch Pediatr Adolesc Med. 1997 Aug;151(8):47-9.
Hardie W, Bokulic R, Garcia VF, Reising SF, Christie CD. Pneumococcal pleural empyemas in children. Clin Infect Dis. 1996 Jun;22(6):1057-63.
Bokulic RE, Hilman BC. Interstitial lung disease in children. Pediatr Clin North Am. 1994 Jun;41(3):543-67.
Lisa A. Burns, MD Pulmonologist, Pediatric and Adult Centers, Division of Pulmonary Medicine 513-636-6771 email@example.com
Pulmonologist, Pediatric and Adult Centers, Division of Pulmonary Medicine
Assistant Professor, UC Department of Pediatrics
Cystic fibrosis; chronic respiratory failure
MD: Loyola University, Chicago, Stritch School of Medicine, 2002.
Residency: Internal Medicine/Pediatrics, St. Louis University, St. Louis, MO.
Certification: ABP, 2006, ABIM, 2007.
Kelly C. Byars, PsyD Pediatric Psychologist, Clinical, Behavioral Medicine & Clinical Psychology 513-636-4336 firstname.lastname@example.org
Pediatric Psychologist, Clinical, Behavioral Medicine & Clinical Psychology
Pediatric behavioral sleep medicine
Kelly C. Byars, PsyD, is a professor of clinical pediatrics for Behavioral Medicine and Clinical Pediatrics at Cincinnati Children's Hospital Medical Center within the UC Department of Pediatrics. Dr. Byars is a pediatric behavioral psychologist who specializes in behavioral assessment and treatment of children with acute and chronic medical conditions. His primary areas of interest are pediatric sleep disorders, pediatric dysphagia and pediatric elimination disorders. Dr. Byars directs the Behavioral Sleep Medicine Program at Cincinnati Children's. He is also involved in the clinical training of postdoctoral fellows and residents.
Dr. Byars' research interests are closely tied to his clinical practice. Dr. Byars has published research focusing on a number pediatric illness groups including feeding disorders, cardiac illness, cancer, sickle cell disease, cystic fibrosis and insulin-dependent diabetes. Dr. Byars collaborates with other investigators at Cincinnati Children's. His current research efforts are focused on improving behavioral assessment and treatment strategies for children with sleep and feeding disorders.
Dr. Byars received his PsyD from the Georgia School of Professional Psychology in Atlanta, GA. He completed an internship in pediatric psychology at the Kennedy Krieger Institute and the Johns Hopkins University School of Medicine. He completed a postdoctoral fellowship in pediatric psychology at Cincinnati Children's. Dr. Byars joined the faculty of Cincinnati Children's and the University of Cincinnati College of Medicine in July 2000.
PsyD: Georgia School of Professional Psychology, Atlanta, GA, 1998.
Residency: Clinical Psychology / Developmental and Behavioral Pediatrics, The Kennedy Krieger Institute and Johns Hopkins University School of Medicine, Baltimore, MD.
Fellowship: Cincinnati Children' s Hospital Medical Center, Cincinnati, Ohio, 2000.
Certification: Licensure in Psychology, State of Ohio, 2000; National Register of Health Service Providers in Psychology, 2001; Certification in Behavioral Sleep Medicine, American Academy of Sleep Medicine, June 2005.
Becker SP, Langberg JM, Byars KC. Advancing a biopsychosocial and contextual model of sleep in adolescence: a review and introduction to the special issue. Journal of Youth and Adolescence. 2015;44:239-270.
Becker SP, Ramsey RR, Byars KC. Convergent Validity of the Child Behavior Checklist sleep items with validated sleep measures and sleep disorder diagnoses in children and adolescents referred to a sleep disorders center. Sleep Medicine. 2015 Jan;16(1):79-86.
Byars K, Simon S. Practice patterns and insomnia treatment outcomes from an evidence-based pediatric behavioral sleep medicine clinic. Clinical Practice in Pediatric Psychology. 2014;2(3):337-349.
Malow B, Byars KC, Johnson Weiss S, Bernal P, Goldman SE, Panzer R, Coury D, Glaze D. A Practice Pathway for the Identification, Evaluation and Management of Insomnia in Children and Adolescents with Autism Spectrum Disorders. Pediatrics. 2012;130:S106.
Beebe DW, Byars KC. Adolescents with obstructive sleep apnea adhere poorly to positive airway pressure (PAP), but PAP users show improved attention and school performance. PLoS One. 2011 Mar 17;6(3):e16924.
Byars K, Apiwattanasawee P, Leejakpai A, Tangchityongsiva S, Simakajornboom N. Behavioral sleep disturbances in children clinically referred for evaluation of obstructive sleep apnea. Sleep Med. 2011 Feb;12(2):163-9.
Byars AW, Byars KC, Johnson CS, DeGrauw TJ, Fastenau PS, Perkins S, Austin JK, Dunn DW. The relationship between sleep problems and neuropsychological functioning in children with first recognized seizures. Epilepsy Behav. 2008 Nov;13(4):607-13.
Meltzer L, Mindell J, Owens J, Byars KC. The Use of Sleep Medications in Hospitalized Pediatric Patients. Pediatrics. 2007;119(6):1047–55.
Byars, K. Scheduled awakenings: A behavioral protocol for treating sleepwalking and sleep terrors in children. In M. Perlis, M. Aloia, and B. Kuhn, (Eds.) Behavioral treatments for sleep disorders: A comprehensive primer of behavioral sleep medicine interventions. London: London: Elsevier Academic Press, 2010.
Byars KC, Amin R. Fatigue and Sleep Disorders. In G. Slapp (Ed.) Adolescent Medicine: The Requisites in Pediatrics. Philadelphia: Elsevier Press, 2008.
Barbara Chini, MD Director, Pulmonary Fellowship Program 513-636-6771 email@example.com
Director, Pulmonary Fellowship Program
Assistant Cystic Fibrosis Center Director, Division of Pulmonary Medicine
BS: University of Notre Dame Notre Dame, IN, 1986.MD: Vanderbilt University Medical School, Nashville, TN, 1990.
Internship: Pediatrics, University of Rochester Medical Center Pediatrics, Rochester, NY, 1991.
Residency: Pediatrics, University of Rochester Medical Center, Rochester, NY, 1993.
Fellowships: University of Rochester Medical Center, Rochester, NY, 1994; Children’s Hospital Medical Center, Cincinnati, OH, 1997.
Fricke BL, Donnelly LF, Shott SR, Kalra M, Poe SA, Chini BA, Amin RS. Comparison of lingual tonsil size as depicted on MR imaging between children with obstructive sleep apnea despite previous tonsillectomy and adenoidectomy and normal controls. Pediatr Radiol. 2006 Jun;36(6):518-23.
Shott SR, Amin R, Chini B, Heubi C, Hotze S, Akers R. Obstructive sleep apnea – Should all children with Down syndrome be tested? Arch Otolaryngol Head Neck Surg. 2006 Apr;132(4):432-436.
Mannaa M, Chini B. A case in point. A boy with shortness of breath, cough, and myalgias. J Respiratory Diseases. 2006;27(8):356-8.
Beebe DW, Wells CT, Jeffries J, Chini B, Kalra M, Amin RS. Neuropsychological Effects of Pediatric Obstructive Sleep Apnea. JINS. 2004 Nov;10(7):962-975.
Abbott MB, Donnelly LF, Dardzinski BJ, Poe SA, Chini BA, Amin RS. Obstructive Sleep Apnea: MR Imaging Volume Segmentation Analysis. Radiology. 2004 Sep;232(3):889-895.
Amin RS, Carroll J, Bean J, Jeffries J, Chini B, Bokulic R, Daniels S. Twenty Four Hour Ambulatory Blood Pressure in Children with Obstructive Sleep Apnea. Am J Respir Crit Care Med. 2004 Apr;169(8):950-56.
Donnelly LF, Shott SR, Connor RL, Chini BA, Amin RS. Causes of Persistent Obstructive Sleep Apnea Despite Previous Tonsillectomy and Adenoidectomy in Children with Down Syndrome as Depicted on Static and Dynamic Cine MRI. AJR. 2004 Jul;183(1):175-181.
John P. Clancy, MD Gunnar Esiason/Cincinnati Bell Chair 513-636-6771 firstname.lastname@example.org
Gunnar Esiason/Cincinnati Bell Chair
Research Director, Division of Pulmonary Medicine
Cystic fibrosis; airway cellular biology; CFTR regulation
John P. Clancy, MD, has served in several leadership roles at Univeristy of Alabama, Cincinnati Children's and within the international cystic fibrosis (CF) community. Some of his leadership roles include membership on the CFF Clinical Research Committee (2003 – present), the CFF-TDN Steering Committee (2002 – 2007), the CFF-TDN Translational Research Center Committee (2008 – present), DSMB membership for the Rare Lung Disease Consortium within the NIH Rare Disease Research Network (2005-2009, Chairman from 2010 – present); organizing committee membership for the North American CF Conference (2003- present) and the European CF Society (2010), Co-chair of the CFFT Biomarkers Consortium (2010- present), member of the Promotion and Tenure Committee for the UAB Department of Pediatrics (2003 - 2010) and the UAB SOM (2007 – 2010, including committee Chair).
Dr. Clancy has been the primary or co-mentor of more than 20 fellows, graduate students and junior faculty. He has been the initial recipient of two endowed chairs, including the Raymond K. Lyrene Chair in Pediatric Pulmonary Medicine at the University of Alabama (2005), and the Tom Boat Chair in Cystic Fibrosis Clinical and Translational Research at Cincinnati Children's (2011).
MD: University of Iowa College of Medicine, Iowa City, IA.
Residency: University of Virginia, Charlottesville, VA.
Fellowship: University of Alabama at Birmingham, Birmingham, AL.
Hug MJ, Derichs N, Bronsveld I, Clancy JP. Measurement of ion transport function in rectal biopsies. Methods Mol Biol. 2011;741:87-107.
Rowe SM, Clancy JP, Wilschanski M. Nasal potential difference measurements to assess CFTR ion channel activity. Methods Mol Biol. 2011;741:69-86.
Accurso FJ, Rowe SM, Clancy JP, Boyle MP, Dunitz JM, Durie PR, Sagel SD, Hornick DB, Konstan MW, Donaldson SH, Moss RB, Pilewski JM, Rubenstein RC, Uluer AZ, Aitken ML, Freedman SD, Rose LM, Mayer-Hamblett N, Dong Q, Zha J, Stone AJ, Olson ER, Ordoñez CL, Campbell PW, Ashlock MA, Ramsey BW. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med. 2010 Nov 18;363(21):1991-2003.
Clancy JP. Diagnosing cystic fibrosis in patients with non-diagnostic results: the case for intestinal current measurements. Thorax. 2010 Jul;65(7):575-6.
Rowe SM, Pyle LC, Jurkevante A, Varga K, Collawn J, Sloane PA, Woodworth B, Mazur M, Fulton J, Fan L, Li Y, Fortenberry J, Sorscher EJ, Clancy JP. DeltaF508 CFTR processing correction and activity in polarized airway and non-airway cell monolayers. Pulm Pharmacol Ther. 2010 Aug;23(4):268-78.
Com G, Clancy JP. Adenosine receptors, cystic fibrosis, and airway hydration. Handb Exp Pharmacol. 2009;(193):363-81.
Rowe SM, Clancy JP. Pharmaceuticals targeting nonsense mutations in genetic diseases: progress in development. BioDrugs. 2009;23(3):165-74.
Rowe SM, Accurso F, Clancy JP. Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trials. Proc Am Thorac Soc. 2007 Aug 1;4(4):387-98. Rowe SM, Varga K, Rab A, Bebok Z, Byram K, Li Y, Sorscher EJ, Clancy JP. Restoration of W1282X CFTR activity by enhanced expression. Am J Respir Cell Mol Biol. 2007 Sep;37(3):347-56.
Daniel H. Grossoehme Chaplain, Division of Pulmonary Medicine 513-636-0848 email@example.com
Chaplain, Division of Pulmonary Medicine
Adherence; spirituality and religion; chronic illness coping and HRQoL.
Visit the Grossoehme Lab.
Doctor of Ministry: (Pastoral Counseling), Louisville Presbyterian Theological Seminary, 2006.
MDiv: Protestant Episcopal Theological Seminary in Virginia, Alexandria, VA, 1992.
BS: Astrophysics, Indiana University, 1985.
Grossoehme DH, Opipari-Arrigan L, VanDyke R, Thurmond S, Seid M. Relationship of adherence determinants and parental spirituality in cystic fibrosis. Pediatr Pulmonol. 2012 Jun;47(6):558-66.
Grossoehme DH, Jacobson CJ, Cotton S, Ragsdale J, VanDyke R, Seid M. Written prayers and religious coping in a paediatric hospital setting. Mental Health, Religion & Culture. 2011 14(5): 423-432.
Grossoehme DH, Ragsdale JR, Snow A, Seid M. We were chosen as a family: Parents’ evolving use of religion when their child has cystic fibrosis. J Relig Health. 2012 Dec;51(4):1347-58.
Cotton S, Grossoehme DH, McGrady M. Religious coping and use of prayer in sickle cell disease. Pediatric Blood Cancer. 2012 Feb;58(2):244-9.
Grossoehme DH, VanDyke R, Jacobson CJ, Cotton S, Ragsdale J, Seid M. Written prayers in a pediatric hospital: linguistic analysis. Psychology of Religion & Spirituality. 2010 2(4): 227-233.
Grossoehme DH, Ragsdale JR, Wooldridge JL, Cotton S, Grimes L, Seid M. Parents’ use of religious coping in the first year after their child’s chronic illness diagnosis. Journal of Health Care Chaplaincy. 2010 16(3): 109-122.
Grossoehme DH, Ragsdale J, Wooldridge JL, Cotton S, Seid M. We can handle this: Parents’ use of religion in the first year following their child’s diagnosis with cystic fibrosis. Journal of Health Care Chaplaincy. 2010 16(3): 95-108.
Grossoehme DH, VanDyke R, Seid M. Spirituality’s role in chronic disease self-management: Sanctification of the body in families dealing with cystic fibrosis. Journal of Health Care Chaplaincy. 2009 15, 1-10.
Cotton S, Grossoehme D, Rosenthal SL, McGrady ME, Roberts YH, Hines J, Yi MS, Tsevat J. Religious/spiritual coping in adolescents with sickle cell disease: A pilot study. Journal of Pediatric Hematology/Oncology. 2009 31(5), 313-318.
Grossoehme DH, Ragsdale J, Dixon C, Berz K, Zimmer M. The changing face of medical education: the role of religion, integrative medicine and osteopathy. The Open Medical Education Journal. 2009 2, 1-8.
William D. Hardie, MD 513-636-6771 firstname.lastname@example.org
Pulmonary function tests; pneumonia; empyema
MD: Vanderbilt University, Nashville, TN, 1990.
Residency: Children's Hospital Medical Center, Cincinnati, OH.
Fellowship: Children's Hospital Medical Center, Cincinnati, OH.
Certification: Pediatrics, 1993; Pulmonary Medicine, 1999.
Le Cras TD, Korfhagen TR, Davidson C, Schmidt S, Fenchel M, Ikegami M, Whitsett JA, Hardie WD. Inhibition of PI3K by PX-866 prevents transforming growth factor-alpha-induced pulmonary fibrosis. Am J Pathol. 2010 Feb;176(2):679-86
Deshmukh HS, McLachlan A, Atkinson JJ, Hardie WD, Korfhagen TR, Dietsch M, Liu Y, Di PY, Wesselkamper SC, Borchers MT, Leikauf GD. Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production. Am J Respir Crit Care Med. 2009 Nov 1;180(9):834-45.
Hardie WD, Glasser SW, Hagood JS. Emerging concepts in the pathogenesis of lung fibrosis. Am J Pathol. 2009 Jul;175(1):3-16.
Korfhagen TR, Le Cras TD, Davidson CR, Schmidt SM, Ikegami M, Whitsett JA, Hardie WD. Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 2009 Nov;41(5):562-72.
Kramer EL, Mushaben EM, Pastura PA, Acciani TH, Deutsch GH, Khurana Hershey GK, Korfhagen TR, Hardie WD, Whitsett JA, Le Cras TD. Early growth response-1 suppresses epidermal growth factor receptor-mediated airway hyperresponsiveness and lung remodeling in mice. Am J Respir Cell Mol Biol. 2009 Oct;41(4):415-25.
Hardie WD. 50 Years Ago in The Journal of Pediatrics Pediatric Empyema: A Second Look at its Incidence and Importance. Kiesewetter, WB, Rusnock JR, Girdany BR. J Pediatr 1959;54:81-6. J Pediatr. 2009 Jan 1;154(1):131.
Loeb JS, Blower WC, Feldstein JF, Koch BA, Munlin AL, Hardie WD. Acceptability and repeatability of spirometry in children using updated ATS/ERS criteria. Pediatr Pulmonol. 2008 Oct;43(10):1020-4.
Hardie WD, Davidson C, Ikegami M, Leikauf GD, Le Cras TD, Prestridge A, Whitsett JA, Korfhagen TR. EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2008 Jun;294(6):L1217-25.
Deshmukh HS, Shaver C, Case LM, Dietsch M, Wesselkamper SC, Hardie WD, Korfhagen TR, Corradi M, Nadel JA, Borchers MT, Leikauf GD. Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production. Am J Respir Cell Mol Biol. 2008 Apr;38(4):446-54.
McPhail GL, Hardie WD. Cavitary lung lesions in a 2-year-old child. Respiration. 2008;76(1):117-8.
Carolyn M. Kercsmar, MD Co-Director, Division of Pulmonary Medicine 513-636-6771 email@example.com
Co-Director, Division of Pulmonary Medicine
Director, Asthma Center
BS: Biology, Baldwin-Wallace College, Cleveland, OH, 1972.
MD: Case Western Reserve University, Cleveland, OH, 1978.
MS: Anatomy, Case Western Reserve University, Cleveland, OH, 1978.
Kercsmar C. Exhaled nitric oxide in the diagnosis and management of childhood asthma. Ther Adv Respir Dis. 2010 Apr;4(2):71-82.
Kattan M, Kumar R, Bloomberg GR, Mitchell HE, Calatroni A, Gergen PJ, Kercsmar CM, Visness CM, Matsui EJ, Steinbach SF, Szefler SJ, Sorkness CA, Morgan WJ, Teach SJ, Gan VJ. Asthma control, adiposity, and adipokines among inner-city adolescents. J Allergy Clin Immunol. 2010 125:584-92.
Rohan J, Drotar D, McNally K, Schluchter M, Riekert K, Vavrek P, Schmidt A, Redline S, Kercsmar C. Adherence to pediatric asthma treatment in economically disadvantaged African-American children and adolescents: an application of growth curve analysis. J Pediatr Psychol. 2010 May;35(4):394-404.
Ross KR, Hart MA, Storfer-Isser A, Kibler AM, Johnson NL, Rosen CL, Kercsmar CM, Redline S. Obesity and obesity related co-morbidities in a referral population of children with asthma. Pediatr Pulmonol. 2009 Sep;44(9):877-84.
McNally KA, Rohan J, Schluchter M, Riekert KA, Vavrek P, Schmidt A, Redline S, Kercsmar C, Drotar D. Adherence to combined montelukast and fluticasone treatment in economically disadvantaged African American youth with asthma. J Asthma. 2009 Nov;46(9):921-7.
Kercsmar CM, McDowell KM. Love it or Lev it: Levalbuterol for severe acute asthma; for now, leave it. J Pediatr. 2009 155:163-64.
Short EJ, Kirchner HL, Asaad GR, Fulton S, Lewis B, Eisengart S, Baley J, Kercsmar C, Min MO, Singer LT. Long-term Sequelae of Postnatal Surfactant and Corticosteroid Therapies. BPD J Perinatol. 2008 Jul; 28(7):498-504.
Szefler SL, Mirchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, Kattan M, Pongracic JA, Teach SJ, , Bloomberg GR, Eggleston PA, Gruchalla RS, Kercsmar CM, Liu, AH, Wildfire JJ, Busse WW. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet. 2008 372:1065-72.
Kercsmar CM. Meeting the challenges of asthma: conference summary. Respir Care. 2008 Jun;53(6):787-95.
Sobande PO, Kercsmar CM. Inhaled corticosteroids in asthma management. Respir Care. 2008 May;53(5):625-33; discussion 633-4. Review.
Karen M. McDowell, MD Director, Infant Pulmonary Function Lab 513-636-6771 firstname.lastname@example.org
Director, Infant Pulmonary Function Lab
Asthma; flexible bronchoscopy; general pediatric pulmonology; quality improvement methodologies; infant pulmonary function test
BS: College of William and Mary, Williamsburg, VA, 1983.
MS: University of Connecticut, Storrs, CT, 1986.
MD: Temple University School of Medicine, Philadelphia, PA, 1990.
Residency: Rainbow Babies and Children's Hospital, Cleveland, OH.
Fellowship: Rainbow Babies and Children's Hospital, Cleveland, OH.
Certification: Pediatric Pulmonology, 1996.
McDowell KM, Craven DI. Pulmonary complications of Down syndrome during childhood. J Pediatr. 2011 Feb;158(2):319-25.
Kercsmar CM, McDowell KM. Love It or Lev It: The Role of Levalbuterol in Acute Severe Asthma—For now, Leave it. J Pediatr. 2009 155(2):162-164.
Richards MM, Banez, GA, McDowell KM. Pediatric Puzzler. Pediatric Perspectives. April 2006.
Ogunmola N, Wyllie R, McDowell K, Kay M, Mahajan L. Endoscopic closure of esophagobronchial fistula with fibrin glue. J Pediatr Gastroenterol Nutr. 2004 38(5): 539-541.
Gary Lewis McPhail, MD Cystic Fibrosis Center Director, Division of Pulmonary Medicine 513-636-6771 email@example.com
Cystic Fibrosis Center Director, Division of Pulmonary Medicine
Associate Director, Fellowship Training Program
Medical education; outcomes research; quality improvement; sleep medicine; thoracic insufficiency syndrome
MD: University of Texas Southwestern Medical Center, Dallas TX, 2001.
Residency: Children's Medical Center, University of Texas Southwestern, Dallas TX, 2004.
Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2007.
Certification: Pediatrics, 2004; Pediatric Pulmonary, 2008.
McPhail GL, Weiland J, Acton JD, Ednick M, Chima A, VanDyke R, Fenchel MC, Amin RS, Seid M. Improving evidence-based care in cystic fibrosis through quality improvement. Arch Pediatr Adolesc Med. 2010 Oct;164(10):957-60.
McPhail GL, Ednick MD, Fenchel MC, VanDyke R, Chima A, Amin RS, Seid M. Improving follow-up in hospitalised children. Qual Saf Health Care. 2010 Oct;19(5):e35
Ednick M, Cohen AP, McPhail GL, Beebe D, Simakajornboon N, Amin RS. A review of the effects of sleep during the first year of life on cognitive, psychomotor, and temperament development. Sleep. 2009 Nov 1;32(11):1449-58. Review.
McPhail GL, Acton JD, Fenchel MC, Amin RS, Seid M. Improvements in lung function outcomes in children with cystic fibrosis are associated with better nutrition, fewer chronic pseudomonas aeruginosa infections, and dornase alfa use. J Pediatr. 2008 Dec;153(6):752-7.
McPhail GL. Coagulation disorder as a presentation of cystic fibrosis. J Emerg Med. 2010 Apr;38(3):320-2.
Amin R, Somers VK, McConnell K, Willging P, Myer C, Sherman M, McPhail G, Morgenthal A, Fenchel M, Bean J, Kimball T, Daniels S. Activity-adjusted 24-hour ambulatory blood pressure and cardiac remodeling in children with sleep disordered breathing. Hypertension. 2008 Jan;51(1):84-91.
McPhail GL, Hardie WD. Cavitary lung lesions in a 2-year-old child. Respiration. 2008;76(1):117-8.
Hemant Sawnani, MD Member, Division of Pulmonary Medicine 513-636-6771 Sleep@cchmc.org
Member, Division of Pulmonary Medicine
Pediatric sleep disorders
MD: Seth GS Medical College/King Edward VIII Memorial Hospital, 1997.
Residency: Pediatrics, Brooklyn Hospital Medical Center, New York NY, 2000.
Fellowship: Pediatric Pulmonology, Tulane Medical Center, New Orleans LA, 2003; Sleep Medicine, Cincinnati Children's Hospital, Cincinnati OH, 2008.
Certification: Pediatrics, 2000, recertified 2007; Pediatric Pulmonology, 2004.
Michael Seid, PhD Director, Health Outcomes and Quality Care Research, Pulmonary Medicine and James M. Anderson Center for Health Systems Excellence 513-803-0083 firstname.lastname@example.org
Director, Health Outcomes and Quality Care Research, Pulmonary Medicine and James M. Anderson Center for Health Systems Excellence
Health care quality and outcomes
Visit the Seid Lab.
Michael Seid, PhD, is director of Health Outcomes and Quality of Care Research in the Division of Pulmonary Medicine and a core faculty in the James M. Anderson Center for Health Systems Excellence at Cincinnati Children's Hospital Medical Center within the UC Department of Pediatrics. Dr. Seid applies behavioral and social science to the question ‘What does it take to make sure the right treatment gets to the right child in the right way at the right time, every time?’
Dr. Seid has worked at the Center for Child Health Outcomes at Children's Hospital, San Diego and was a behavioral / research scientist at the RAND Corporation. He has been principal and co-principal investigator of several large multidisciplinary research studies, collaborates with investigators at Cincinnati Children's and beyond, and publishes widely in such journals as Medical Care, HSR: Health Services Research, Archives of Pediatrics and Adolescent Medicine, Pediatrics, American Journal of Medical Quality, the Journal of Ambulatory Pediatrics, and Milbank Quarterly.
Dr. Seid has served as the chair of Children's Hospital San Diego's Institutional Review Board, as a member of the Health Care Quality and Effectiveness Research (HCQER) Study Section at the Agency for Healthcare Quality and Research, and on several national and local expert panels. He is on the Review Board of the Journal of Clinical Outcomes Management and an ad hoc reviewer for Health Services Research, Pediatrics and the Journal of Ambulatory Pediatrics.
Grossoehme DH, Ragsdale JR, Snow A, Seid M. We were Chosen as a Family: Parents' Evolving Use of Religion when Their Child has Cystic Fibrosis. J Relig Health. 2011 Mar 16.
Muething SE, Conway PH, Kloppenborg E, Lesko A, Schoettker PJ, Seid M, Kotagal U. Identifying causes of adverse events detected by an automated trigger tool through in-depth analysis. Qual Saf Health Care. 2010 Oct;19(5):435-9.
Grossoehme DH, Ragsdale J, Cotton S, Wooldridge JL, Grimes L, Seid M. Parents' religious coping styles in the first year after their child's cystic fibrosis diagnosis. J Health Care Chaplain. 2010 Jul;16(3-4):109-22.
Grossoehme DH, Ragsdale J, Wooldridge JL, Cotton S, Seid M. We can handle this: parents' use of religion in the first year following their child's diagnosis with cystic fibrosis. J Health Care Chaplain. 2010 Jul;16(3-4):95-108.
Stevens GD, Seid M, Pickering TA, Tsai KY. National disparities in the quality of a medical home for children. Matern Child Health J. 2010 Jul;14(4):580-9.
Ernst MM, Wooldridge JL, Conway E, Dressman K, Weiland J, Tucker K, Seid M. Using Quality Improvement Science to Implement a Multidisciplinary Behavioral Intervention Targeting Pediatric Inpatient Airway Clearance. J Pediatr Psychol. 2010 Jan-Feb; 35(1):1.
Seid M, Limbers CA, Driscoll KA, Opipari-Arrigan LA, Gelhard LR, & Varni JW. Reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory™ (PedsQL™) Generic Core Scales and Asthma Symptoms Scale in vulnerable children with asthma. Journal of Asthma. 2010;47:170-177.
Wirtschafter DD, Pettit J, Kurtin P, Dalsey M, Chance K, Morrow HW, Seid M, Byczkowski TL, Huber TP, Milstein JM, Bowles SM, Fichera S, Kloman S. A statewide quality improvement collaborative to reduce neonatal central line-associated blood stream infections. J Perinatol. 2010 Mar;30(3):170-81.
Fairbrother G, Cassedy A, Ortega-Sanchez IR, Szilagyi PG, Edwards KM, Molinari NA, Donauer S, Henderson D, Ambrose S, Kent D, Poehling K, Weinberg GA, Griffin MR, Hall CB, Finelli L, Bridges C, Staat MA; New Vaccine Surveillance Network (NVSN). High costs of influenza: Direct medical costs of influenza disease in young children. Vaccine. 2010 Jul 12;28(31):4913-9.
Rhonda D. Szczesniak, PhD 513-803-0563 email@example.com
PhD: Statistics, University of Kentucky, Lexington, KY, 2007.
MS: Statistics, University of Kentucky, Lexington, KY, 2005.
BS: Mathematics, Radford University, Radford, VA, 2003.
Grossoehme DH, Szczesniak R, Dodd C, Opipari-Arrigan L. Dyadic Adjustment and Spiritual Activities in Parents of Children with Cystic Fibrosis. Religions. Jun 2014;5(2):385-401.
Tan CC, McDowell KM, Fenchel M, Szczesniak R, Kercsmar CM. Spirometry Use in Children Hospitalized With Asthma. Pediatr Pulmonol. May 2014;49(5):451-457.
Szczesniak RD, McPhail GL, Duan LL, Macaluso M, Amin RS, Clancy JP. A semiparametric approach to estimate rapid lung function decline in cystic fibrosis. Annals of epidemiology. Dec 2013 2013;23(12):771-777.
Clancy JP, Szczesniak RD, Ashlock MA, et al. Multicenter Intestinal Current Measurements in Rectal Biopsies from CF and Non-CF Subjects to Monitor CFTR Function. PLoS One. Sep 2013;8(9):13.
Cudzilo CJ, Szczesniak RD, Brody AS, et al. Lymphangioleiomyomatosis Screening in Women With Tuberous Sclerosis. Chest. Aug 2013;144(2):578-585.
Pediatric Sleep Research Program. Biostatistics Mentor. K24 NIH/NHLBI. March 2011-Feb 2016.
MR predictors of infection, inflammation, and structural lung damage in CF. Biostatistician. R01 NIH. Sep 2012-June 2016.
Bruce C. Trapnell, MS, MD Assistant Director, Adult Cystic Fibrosis Center 513-636-6361 firstname.lastname@example.org
Assistant Director, Adult Cystic Fibrosis Center
Pulmonologist - Research, Adult Clinical, Division of Pulmonary Medicine
Pulmonary alveolar proteinosis; cystic fibrosis; alpha-1 antitrypsin deficiency; other rare lung disorders
Bruce Trapnell, MS, MD, received his medical degree from the University of Maryland in 1985, and completed a medical residency at The Ohio State University Hospitals and a fellowship in pulmonary medicine at the Clinical Center of the National Institutes of Health, where he then served as senior attending physician. Subsequently, he established the Division of Pulmonary and Virology Studies at Genetic Therapy, Inc., a subsidiary of Novartis, Pharma, serving as vice president before joining Cincinnati Children’s Hospital Medical Center, where he is now full professor.
Dr. Trapnell has conducted lung disease research since his training and has been continuously funded by the NIH since 2001, shortly after his arrival in Cincinnati. He has published over 90 original articles and has trained more than 16 post-doctoral fellows. Dr. Trapnell’s research interests are focused to the pathogenesis and therapy of rare lung diseases and mechanisms by which GM-CSF regulates innate immunity and lung host defense.
Dr. Trapnell is director of Cincinnati’s Cystic Fibrosis Therapeutics Development Network Center, assistant director of the Adult Cystic Fibrosis Care Center, director of the Rare Lung Diseases Clinical Research Consortium, scientific director of the Pulmonary Alveolar Proteinosis Foundation. Dr. Trapnell is the past scientific director of the Alpha-1 Foundation, for which he organized and directed the grant program for eight years.
MS: Genetics, The George Washington University, Washington, DC, 1981.
MD: University of Maryland School of Medicine, Baltimore, MD, 1984.
Residency: Internal Medicine, The Ohio State University Hospitals, Columbus, OH, 1987.
Fellowship: Pulmonary Medicine, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD, 1989.
Certification: Diplomate in Internal Medicine, American Board of Internal Medicine, 1987; Diplomate, National Board of Medical Examiners, 1987; Diplomate in Pulmonary Medicine, American Board of Internal Medicine, 2000.
Wu H, Suzuki T, Carey B, Trapnell BC, McCormack FX. Keratinocyte growth factor (KGF) augments pulmonary innate immunity through epithelium-driven, GM-CSF dependent paracrine activation of alveolar macrophages. J Biol Chem. 2011 Feb 22.
D'Mello S, Trauernicht A, Ryan A, Bonkowski E, Willson T, Trapnell BC, Frank SJ, Kugasathan S, Denson LA. Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis. Inflamm Bowel Dis. 2011 Feb 18.
Suzuki T, Sakagami T, Young LR, Carey BC, Wood RE, Luisetti M, Wert SE, Rubin BK, Kevill K, Chalk C, Whitsett JA, Stevens C, Nogee LM, Campo I, Trapnell BC. Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy. Am J Respir Crit Care Med. 2010 Nov 15;182(10):1292-304.
Young LR, Vandyke R, Gulleman PM, Inoue Y, Brown KK, Schmidt LS, Linehan WM, Hajjar F, Kinder BW, Trapnell BC, Bissler JJ, Franz DN, McCormack FX. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest. 2010 Sep;138(3):674-81.
Han X, Gilbert S, Groschwitz K, Hogan S, Jurickova I, Trapnell B, Samson C, Gully J. Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury. Gut. 2010 Aug;59(8):1066-78.
Sakagami T, Beck D, Uchida K, Suzuki T, Carey BC, Nakata K, Keller G, Wood RE, Wert SE, Ikegami M, Whitsett JA, Luisetti M, Davies S, Krischer JP, Brody A, Ryckman F, Trapnell BC. Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. Am J Respir Crit Care Med. 2010 Jul 1;182(1):49-61.
Carey B, Trapnell BC. The molecular basis of pulmonary alveolar proteinosis. Clin Immunol. 2010 May;135(2):223-35.
Trapnell BC, Maguiness K, Graff GR, Boyd D, Beckmann K, Caras S. Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis. J Cyst Fibros. 2009 Dec;8(6):370-7.
Trapnell BC, Carey BC, Uchida K, Suzuki T. Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages. Curr Opin Immunol. 2009 Oct;21(5):514-21.
Uchida K, Nakata K, Suzuki T, Luisetti M, Watanabe M, Koch DE, Stevens CA, Beck DC, Denson LA, Carey BC, Keicho N, Krischer JP, Yamada Y, Trapnell BC. Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood. 2009 Mar 12;113(11):2547-56.
Robert E. Wood, PhD, MD Director, Pulmonary Bronchoscopy Department 513-636-6771 email@example.com
Director, Pulmonary Bronchoscopy Department
Dr. Robert Wood, PhD, MD, is a pediatric pulmonary specialist, with particular interest in bronchoscopy. He has played a major role in the development of instrumentation and techniques for flexible bronchoscopy in pediatric patients. He is recognized as a teacher of endoscopic techniques, and has published many papers and book chapters on the subject. Additionally, he has extensive experience with clinical problems in pediatric pulmonary medicine, especially children with complex airway problems and cystic fibrosis.
Before coming to Cincinnati Children's Hospital Medical Center, Dr. Wood was on the faculty of Case Western Reserve University in Cleveland, Ohio (1976 to 1983), and the University of North Carolina at Chapel Hill (1983 to 1999).
PhD: Medical Physiology, Vanderbilt University, Nashville, TN, 1968.
MD: Vanderbilt University, Nashville, TN, 1970.
Residency: Pediatrics, Duke University Medical Center, Durham, NC, 1970 to 1972.
Fellowship: Pediatric Metabolism, National Institute of Arthritis, Metabolism, and Digestive Diseases, Bethesda, MD, 1972 to 1974; Pediatric Pulmonology, Case Western Reserve University, Cleveland, OH; Rainbow Babies and Children's Hospital, Cleveland, OH, 1974 to 1976.
Certification: Pediatrics, 1976; Pediatric Pulmonology, 1986, 1997.
Abman S, Jobe A, Chernick V, Blaisdell C, Castro M, Ramirez MI, Gern JE, Cutting G, Redding G, Hagood JS, Whitsett J, Abman S, Raj JU, Barst R, Kato GJ, Gozal D, Haddad GG, Prabhakar NR, Gauda E, Martinez FD, Tepper R, Wood RE, Accurso F, Teague WG, Venegas J, Cole FS, Wright RJ, Gail D, Hamvas A, Kercsmar C, Kiley J, Weinmann G; NHLBI working group report. Strategic plan for pediatric respiratory diseases research: an NHLBI working group report. Pediatr Pulmonol. 2009 Jan;44(1):2-13.
Muenzer J, Beck M, Eng CM, Escolar ML, Giugliani R, Guffon NH, Harmatz P, Kamin W, Kampmann C, Kosepglu ST, Link B, Martin RA, Molter DW, MuAoz Rojas MV, Ogilvie JW, Parini R, Ramaswami U, Scarpa M, Schwartz IV, Wood RE, Wraith E. Multidisciplinary Management of Hunter Syndrome. Pediatrics. 2009; 124:e1228-39.
Suzuki T, Sakagami T, Rubin BK, Nogee LM, Wood RE, Zimmerman SL, Smolarek T, Dishop MK, Wert SE, Whitsett JA, Grabowski G, Carey BC, Stevens C, van der Loo JC, Trapnell BC. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. J Exp Med. 2008 Nov 24;205(12):2703-10.
Wood RE. Evaluation of the upper airway in children. Curr Opin Pediatr. 2008 Jun;20(3):266-71. Review.
Boesch RP, Daines C, Willging JP, Kaul A, Cohen AP, Wood RE, Amin RS. Advances in the diagnosis and management of chronic pulmonary aspiration in children. Eur Respir J. 2006 Oct;28(4):847-61. Review.
Zur KB, Wood RE, Elluru RG. Pediatric postcricoid vascular malformation: a diagnostic and treatment challenge. Int J Pediatr Otorhinolaryngol. 2005 Dec;69(12):1697-701.
Lim LH, Cotton RT, Azizkhan RG, Wood RE, Cohen AP, Rutter MJ. Complications of metallic stents in the pediatric airway. Otolaryngol Head Neck Surg. 2004 Oct;131(4):355-61.
Wood RE. The emerging role of flexible bronchoscopy in pediatrics. Clin Chest Med. 2001 Jun;22(2):311-7, viii. Review.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2015 Cincinnati Children's Hospital Medical Center